8 November, 2025
australia-faces-record-whooping-cough-outbreak-amid-vaccine-shortfall

Hospitals across Australia are missing a critical opportunity to vaccinate more citizens against whooping cough, a disease currently spreading at unprecedented rates. A recent investigation by the Immunisation Foundation of Australia reveals that a significant number of hospitals are not stocking the whooping cough-containing booster necessary for patients with tetanus-prone wounds.

This oversight persists despite health guidelines that recommend the use of a combined vaccine in emergency departments to enhance protection against whooping cough, also known as pertussis. Studies indicate that immunisation levels are “concerningly low,” raising alarms among health professionals.

Unprecedented Outbreak and Its Implications

Australia is grappling with an unprecedented outbreak of whooping cough, an infection particularly dangerous for infants and young children. Authorities have reported 80,000 cases in the past two years alone, marking an all-time high. Known as the “100-day cough,” this bacterial infection severely impacts the airways, leading to uncontrollable coughing and difficulty breathing. It is more contagious than both the flu and COVID-19.

Catherine Hughes, founder of the Immunisation Foundation, expressed concern over the missed opportunities to increase vaccination rates against this life-threatening disease. “It’s unacceptable that so many vaccines used for tetanus in Australian hospitals do not include added protection against whooping cough, despite established national recommendations,” she stated. Hughes’ advocacy is deeply personal, as she lost her 32-day-old son Riley to the disease a decade ago.

Current Vaccination Practices Under Scrutiny

The foundation’s probe discovered that 401 out of 469 hospitals are currently stocking the older diphtheria and tetanus vaccine, which lacks the additional protection against whooping cough. This choice is made despite the fact that the combined vaccine costs only a few dollars more per dose. Previous research has shown that one million adults over the age of 50 received the older vaccine instead of the recommended combined jab when seeking tetanus protection.

Raina MacIntyre, head of global biosecurity at UNSW’s Kirby Institute, emphasized the importance of vaccinating adults to manage the outbreak. “Adults are a large component of the massive pertussis epidemic we’ve seen unfold in Australia, so vaccination of adults is part of the solution,” Professor MacIntyre explained.

Historical Context and Future Steps

The current situation recalls past epidemics where vaccine hesitancy and logistical challenges led to widespread outbreaks. The need for comprehensive vaccination strategies is underscored by the historical success of immunisation programs in controlling diseases such as polio and measles.

Looking forward, health authorities and hospitals must collaborate to ensure the availability and use of the combined vaccine. Public health campaigns could play a crucial role in raising awareness about the importance of adult vaccination, particularly in light of the current outbreak.

As Australia navigates this public health challenge, the lessons learned could inform future strategies to prevent similar situations. The Immunisation Foundation’s findings highlight a pressing need for policy adjustments and increased vigilance in vaccine administration practices.

In conclusion, addressing the gaps in whooping cough vaccination is vital to protect vulnerable populations and curb the current epidemic. The healthcare system’s response in the coming months will be critical in determining the trajectory of this outbreak.